Co-Diagnostics, Inc.
General ticker "CODX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $14.2M (TTM average)
Co-Diagnostics, Inc. does not follow the US Stock Market performance with the rate: -8.4%.
Estimated limits based on current volatility of 4.1%: low 1.41$, high 1.53$
Factors to consider:
- Total employees count: 155 (+6.9%) as of 2023
- US accounted for 72.1% of revenue in the fiscal year ended 2022-12-31
- Top business risk factors: Regulatory and compliance, Product development delays, Cybersecurity threats, Labor/talent shortage/retention, Operational and conduct risks
- Current price 67.9% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.86$, 14.41$]
- 2026-12-31 to 2027-12-31 estimated range: [2.94$, 9.35$]
Short-term CODX quotes
Long-term CODX plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.42MM |
| Operating Expenses | $31.91MM |
| Operating Income | $-31.49MM |
| Non-Operating Income | $-17.02MM |
| R&D Expense | $19.14MM |
| Income(Loss) | $-48.51MM |
| Taxes | $-1.62MM |
| Profit(Loss)* | $-46.90MM |
| Stockholders Equity | $20.63MM |
| Inventory | $0.99MM |
| Assets | $24.74MM |
| Operating Cash Flow | $-29.14MM |
| Capital expenditure | $0.70MM |
| Investing Cash Flow | $26.27MM |
| Financing Cash Flow | $11.81MM |
| Earnings Per Share** | $-35.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.